Trial intelligence / Profile preview

Celecoxib with Chemoradiotherapy for Esophageal Cancer

NCT00520091Phase 2Completed

Sponsor
UNC Lineberger Comprehensive Cancer Center
Start
Mar 2005
Primary completion
Nov 2006
Modality
Small Molecules
01

Overview

A Phase 2 trial of celecoxib oral solution in esophageal cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 2005; status: completed.

02

Drugs

celecoxib oral solution
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00520091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00520091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call